DNA
nanosheets (DNSs) have been utilized effectively as a fluorescence
anisotropy (FA) amplifier for biosensing. But, their sensitivity needs
to be further improved. Herein, CRISPR-Cas12a with strong trans-cleavage activity was utilized to enhance the FA amplification
ability of DNSs for the sensitive detection of miRNA-155 (miR-155)
as a proof-of-principle target. In this method, the hybrid of the
recognition probe of miR-155 (T1) and a blocker sequence (T2) was
immobilized on the surface of magnetic beads (MBs). In the presence
of miR-155, T2 was released by a strand displacement reaction, which
activated the trans-cleavage activity of CRISPR-Cas12a.
The single-stranded DNA (ssDNA) probe modified with a carboxytetramethylrhodamine
(TAMRA) fluorophore was cleaved in large quantities and could not
bind to the handle chain on DNSs, inducing a low FA value. In contrast,
in the absence of miR-155, T2 could not be released and the trans-cleavage activity of CRISPR-Cas12a could not be activated.
The TAMRA-modified ssDNA probe remained intact and was complementary
to the handle chain on the DNSs, and a high FA value was obtained.
Thus, miR-155 was detected through the obviously decreased FA value
with a low limit of detection (LOD) of 40 pM. Impressively, the sensitivity
of this method was greatly improved about 322 times by CRISPR-Cas12a,
confirming the amazing signal amplification ability of CRISPR-Cas12a.
At the same time, the SARS-CoV-2 nucleocapsid protein was detected
by the strategy successfully, indicating that this method was general.
Moreover, this method has been applied in the analysis of miR-155
in human serum and the lysates of cells, which provides a new avenue
for the sensitive determination of biomarkers in biochemical research
and disease diagnosis.